Literature DB >> 17610420

The genetic variation of the human HMGB1 gene.

B Kornblit1, L Munthe-Fog, S L Petersen, H O Madsen, L Vindeløv, P Garred.   

Abstract

High-mobility group box 1 protein (HMGB1) is a nuclear DNA-binding protein, which also functions as a pleiotropic cytokine, implicated in the pathology of several different immune-mediated diseases. The purpose of this study was to examine the HMGB1 gene for putative polymorphisms in 103 healthy Caucasian Danish blood donors. A total of six polymorphisms and four mutations were identified in the HMGB1 gene. Subsequent MatInspector estimation revealed that several polymorphisms might have a potential regulatory impact on HMGB1 transcription. This study has characterized genetic variations in the HMGB1 gene locus, which may have a regulating role in the expression of HMGB1, providing the basis for molecular investigations of the HMGB1 gene in different disease settings.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17610420     DOI: 10.1111/j.1399-0039.2007.00854.x

Source DB:  PubMed          Journal:  Tissue Antigens        ISSN: 0001-2815


  16 in total

Review 1.  Post-translational modifications of high mobility group box 1 and cancer.

Authors:  Seidu A Richard; Yuanyuan Jiang; Lu Hong Xiang; Shanshan Zhou; Jia Wang; Zhaoliang Su; Huaxi Xu
Journal:  Am J Transl Res       Date:  2017-12-15       Impact factor: 4.060

2.  Cytosolic HMGB1 controls the cellular autophagy/apoptosis checkpoint during inflammation.

Authors:  Xiaorong Zhu; Jeannette S Messer; Yunwei Wang; Fanfei Lin; Candace M Cham; Jonathan Chang; Timothy R Billiar; Michael T Lotze; David L Boone; Eugene B Chang
Journal:  J Clin Invest       Date:  2015-02-02       Impact factor: 14.808

3.  Association of single-nucleotide polymorphisms of high-mobility group box 1 with susceptibility and clinicopathological characteristics of uterine cervical neoplasia in Taiwanese women.

Authors:  Hsin-Hung Wu; Yu-Fan Liu; Shun-Fa Yang; Wea-Lung Lin; Shiuan-Chih Chen; Chih-Ping Han; Hsiang-Ling Wang; Long-Yau Lin; Po-Hui Wang
Journal:  Tumour Biol       Date:  2016-10-04

Review 4.  High Mobility Group Proteins in Sepsis.

Authors:  Guibin Liang; Zhihui He
Journal:  Front Immunol       Date:  2022-06-02       Impact factor: 8.786

5.  High mobility group protein B1 is an activator of apoptotic response to antimetabolite drugs.

Authors:  Natalia Krynetskaia; Hongbo Xie; Slobodan Vucetic; Zoran Obradovic; Evgeny Krynetskiy
Journal:  Mol Pharmacol       Date:  2007-10-19       Impact factor: 4.436

6.  HMGB1 gene polymorphisms in patients with chronic hepatitis B virus infection.

Authors:  Chun-Qing Deng; Guo-Hong Deng; Yu-Ming Wang
Journal:  World J Gastroenterol       Date:  2013-08-21       Impact factor: 5.742

Review 7.  HMGB1 in health and disease.

Authors:  Rui Kang; Ruochan Chen; Qiuhong Zhang; Wen Hou; Sha Wu; Lizhi Cao; Jin Huang; Yan Yu; Xue-Gong Fan; Zhengwen Yan; Xiaofang Sun; Haichao Wang; Qingde Wang; Allan Tsung; Timothy R Billiar; Herbert J Zeh; Michael T Lotze; Daolin Tang
Journal:  Mol Aspects Med       Date:  2014-07-08

8.  High mobility group box 1 gene polymorphism is associated with the risk of postoperative atrial fibrillation after coronary artery bypass surgery.

Authors:  Can Qu; Xiao-Wen Wang; Chun Huang; Feng Qiu; Xiao-Yong Xiang; Zhi-Qian Lu
Journal:  J Cardiothorac Surg       Date:  2015-06-25       Impact factor: 1.637

9.  HMGB1 and HMGB2 proteins up-regulate cellular expression of human topoisomerase IIalpha.

Authors:  Michal Stros; Eva Polanská; Sona Struncová; Sárka Pospísilová
Journal:  Nucleic Acids Res       Date:  2009-02-17       Impact factor: 16.971

10.  Association of HMGB1 polymorphisms with outcome in patients with systemic inflammatory response syndrome.

Authors:  Brian Kornblit; Lea Munthe-Fog; Hans O Madsen; Jens Strøm; Lars Vindeløv; Peter Garred
Journal:  Crit Care       Date:  2008-06-24       Impact factor: 9.097

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.